• Users Online: 305
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 
CASE REPORT
Year : 2015  |  Volume : 7  |  Issue : 1  |  Page : 31-36

Mixed medullary-follicular thyroid cancer treated with surgery and radioiodine ablation: An illustrative case


1 Endocrine, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates
2 Histopathology, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates
3 Oncology Units, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates

Correspondence Address:
Alaaeldin MK Bashier
Endocrine, Dubai Hospital, Dubai Health Authority, Dubai
United Arab Emirates
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1947-489X.210267

Rights and Permissions

Introduction: Differentiated thyroid cancer is the commonest cancer affecting thyroid gland. Medullary thyroid carcinoma (MTC) constitutes only 2-8% of all thyroid cancers. Simultaneous occurrence of mixed medullary and follicular thyroid carcinoma (mixed MTCFTC) is rare. This may pose challenges in diagnosis, treatment, follow up and future prediction of prognosis. Case presentation: A 24 -year-old female presented with a neck swelling that increased in size over 2 months period. She was clinically and biochemically euthyroid. Thyroid Technetium Pertechnetate (99mTcO4) scan showed a cold nodule in the right lobe and ultrasound thyroid confirmed the presence of hypo-echoic well defined lesion. Fine needle aspiration biopsy (FNAB) revealed a medullary thyroid cancer. She underwent total thyroidectomy and lymph node dissection. The histopathology showed a solitary tumor with mixed features, predominantly medullary with areas of follicular architecture, confirmed by immunohistochemical staining as mixed MTC-FTC. Work up for MEN II and RET-proto-oncogen was negative. Postoperative isotope scan showed an increased uptake in the remnant thyroid tissue. She was treated with adjuvant radioactive iodine therapy. Her initial calcitonin level post operatively was 13.4 pg/ml (NR < 5.0), CEA 36 ng/ml (NR <3.8), and thyroglobulin was 0.7 ng/ml (NR <1). On follow up visits, the thyroglobulin as well as calcitonin and CEA levels were all suppressed. Conclusion: Cases of mixed follicular and medullary cancer present significant diagnostic and management challenges. Although we have managed our case surgically as well as by radioactive iodine and we are satisfied that follow up with calcitonin and thyroglobulin did not show any evidence of recurrence, we propose that mixed tumors be included in thyroid cancer management guidelines.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed431    
    Printed38    
    Emailed0    
    PDF Downloaded65    
    Comments [Add]    

Recommend this journal